Article Text

PDF
Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors
  1. Xavier Mariette1,
  2. Alan Vaughan Reynolds2,
  3. Paul Emery3
  1. 1Service de Rhumatologie, Université Paris-Sud, AP-HP, Le Kremlin Bicetre, France
  2. 2Reynolds Clinical Sciences Ltd, Eastleigh, Hampshire, UK
  3. 3Section of Musculoskeletal Disease, University of Leeds, Leeds, UK
  1. Correspondence to Professor Xavier Mariette, Service de Rhumatologie, Le Kremlin Bicetre 94275, France; xavier.mariette{at}bct.aphp.fr

Statistics from Altmetric.com

We recently published a meta-analysis of malignancy rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors (TNF-I).1 While there was no increase in the rates of all-site malignancy or lymphoma, there was an increased risk of non-melanoma skin cancer (NMSC) (1.45, 95% CI 1.15 to 1.76).

The skin cancer analysis included data from an abstract from the British Society for Rheumatology Biologics Register (BSRBR)2 that has since been published as a full paper with different …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.